Overview: T-Cell Profile TestIntroduction: The T-Cell Profile Test analyzes T-cell populations to diagnose immune disorders or infections, helping manage conditions causing frequent infections or fatigue. Affecting 1 in 500 people with immune issues, T-cell imbalances pose diagnostic challenges due to variable presentation. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses flow cytometry for high accuracy, supporting immunology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in immunology.
Other Names: T-Cell Subset Test, Immune Profile Assay.
FDA Status: FDA-approved test, meeting immunology standards for diagnostic reliability.
Historical Milestone: T-cell profile testing began in the 1980s with research by Reinherz, who identified subsets. Flow cytometry advancements by BD Biosciences improved detection, surpassing earlier manual methods.
Purpose: Analyzes T-cell subsets to diagnose immune disorders or infections, guides immunotherapy or antivirals, and evaluates patients with frequent infections, aiming to manage disease.
Test Parameters: T-cell subsets
Pretest Condition: No special preparation required. Collect whole blood. Report history of immune issues.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in Na Heparin tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not recommended
Medical History: Document frequent infections or fatigue. Include current medications or exposure history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., immunodeficiency), and sample collection risks.
Procedural Considerations: Uses flow cytometry to analyze populations, requiring labs with specialized equipment. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Medications may alter counts, requiring correlation.
Clinical Significance: Abnormal subsets suggest immune disorders, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal subsets may require other tests.
Specialist Consultation: Consult an immunologist for interpretation.
Additional Supporting Tests: Immunoglobulin levels, HIV test, or genetic screening to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False results possible with technical errors.
References: CDC Guidelines, 2023; Journal of Immunology, Reinherz EL, 2022.
